Department of Medicine, Division of Rheumatology University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA.
University of Cyprus Medical School, Nicosia, Cyprus.
Curr Rheumatol Rep. 2024 Nov;26(11):375-382. doi: 10.1007/s11926-024-01158-5. Epub 2024 Aug 5.
This review provides an overview of medical conditions and risk factors associated with CPPD.
Recent studies have indicated that CPPD patients may have a higher risk for systemic conditions such as cardiovascular diseases. Calcium pyrophosphate deposition disease (CPPD) is a common crystal arthropathy that primarily affects older adults, and, in most cases, the aetiology is idiopathic. Age is the most remarkable risk factor and due to the aging population, the prevalence of this condition is expected to increase. Strong evidence supports an association between CPPD and several metabolic and endocrine conditions, including hemochromatosis, hyperparathyroidism, hypomagnesemia, and hypophosphatasia. Additionally, there is growing evidence of an increased risk for cardiovascular diseases among CPPD patients, alongside potential links to rheumatic disorders, gender, medications, and joint trauma. Further research is needed to explore the underlying mechanisms linking CPPD to associated conditions and to develop targeted therapies with the aim of improving patient outcomes.
本文概述了 CPPD 相关的医学状况和风险因素。
最近的研究表明,CPPD 患者可能存在更高的全身性疾病风险,如心血管疾病。焦磷酸钙沉积病(CPPD)是一种常见的晶体关节病,主要影响老年人,在大多数情况下,病因是特发性的。年龄是最显著的风险因素,由于人口老龄化,这种疾病的患病率预计将会增加。强有力的证据支持 CPPD 与几种代谢和内分泌疾病之间存在关联,包括血色病、甲状旁腺功能亢进、低镁血症和低磷酸酶血症。此外,越来越多的证据表明 CPPD 患者患心血管疾病的风险增加,同时也可能与风湿性疾病、性别、药物和关节创伤有关。需要进一步的研究来探讨 CPPD 与相关疾病之间的潜在机制,并开发靶向治疗方法,以改善患者的预后。